Contact

All Stories

  1. Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity – a consensus of the Biomarkers Task Force from the WFSBP

    Article • The World Journal of Biological Psychiatry, March 2019, Taylor & Francis

    Dr Edna Grünblatt, Dr Brisa Fernandes, Kamyar Keramatian

  2. Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies

    Article • Journal of Psychiatric Research, August 2018, Elsevier

    Dr Brisa Fernandes

  3. Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives

    Article • Journal of Affective Disorders, October 2017, Elsevier

    Dr Brisa Fernandes

  4. The renin–angiotensin system: a possible new target for depression

    Article • BMC Medicine, August 2017, Springer Science + Business Media

    Dr Brisa Fernandes

  5. Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials

    Article • Australian & New Zealand Journal of Psychiatry, July 2017, SAGE Publications

    Dr Brisa Fernandes

  6. The effect of N-acetylcysteine (NAC) on human cognition – A systematic review

    Article • Neuroscience & Biobehavioral Reviews, July 2017, Elsevier

    Dr Brisa Fernandes

  7. Relationship between depression and frailty in older adults: A systematic review and meta-analysis

    Article • Ageing Research Reviews, July 2017, Elsevier

    Dr Brisa Fernandes

  8. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis

    Article • Molecular Neurobiology, June 2017, Springer Science + Business Media

    Dr Brisa Fernandes

  9. Staging in bipolar disorder: one step closer to precision psychiatry

    Article • Brazilian Journal of Psychiatry, June 2017, FapUNIFESP (SciELO)

    Dr Brisa Fernandes

  10. Homocysteine as a peripheral biomarker in bipolar disorder: A meta-analysis

    Article • European Psychiatry, June 2017, Elsevier

    Dr Brisa Fernandes

  11. 338. Enabling Precision Psychiatry through ‘omics’: From Biomarkers to Biological Pathways

    Article • Biological Psychiatry, May 2017, Elsevier

    Dr Brisa Fernandes

  12. 980. Insulin is a State Biomarker in Major Depressive Disorder: A Systematic Review and Meta-Analysis

    Article • Biological Psychiatry, May 2017, Elsevier

    Dr Brisa Fernandes

  13. Oxidative stress and frailty: A systematic review and synthesis of the best evidence

    Article • Maturitas, May 2017, Elsevier

    Dr Brisa Fernandes

  14. The new field of ‘precision psychiatry’

    Article • BMC Medicine, April 2017, Springer Science + Business Media

    Dr Brisa Fernandes

  15. The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment Outcomes

    Article • Clinical Therapeutics, March 2017, Elsevier

    Dr Brisa Fernandes

  16. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies

    Article • Acta Psychiatrica Scandinavica, January 2017, Wiley

    Dr Brisa Fernandes

  17. Depression in cancer: The many biobehavioral pathways driving tumor progression

    Article • Cancer Treatment Reviews, January 2017, Elsevier

    Dr Brisa Fernandes

  18. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis

    Article • The Lancet Psychiatry, December 2016, Elsevier

    Dr Brisa Fernandes

  19. Affective temperaments and emotional traits are associated with a positive screening for premenstrual dysphoric disorder

    Article • Comprehensive Psychiatry, November 2016, Elsevier

    Dr Brisa Fernandes

  20. Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials

    Article • Journal of Affective Disorders, August 2016, Elsevier

    Dr Brisa Fernandes

  21. Angiotensin Converting Enzyme Inhibitors and Risk of Mood Disorders

    Article • Psychotherapy and Psychosomatics, May 2016, Karger Publishers

    Dr Brisa Fernandes

  22. Bias in emerging biomarkers for bipolar disorder

    Article • Psychological Medicine, May 2016, Cambridge University Press

    Dr Brisa Fernandes

  23. T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model

    Article • Neuroscience & Biobehavioral Reviews, May 2016, Elsevier

    Dr Brisa Fernandes, George Anderson

  24. Leptin in bipolar disorder: A systematic review and meta-analysis

    Article • European Psychiatry, May 2016, Elsevier

    Dr Brisa Fernandes

  25. N-Acetylcysteine in Depressive Symptoms and Functionality

    Article • The Journal of Clinical Psychiatry, April 2016, Physicians Postgraduate Press, Inc

    Dr Brisa Fernandes

  26. Cognitive remission: a novel objective for the treatment of major depression?

    Article • BMC Medicine, January 2016, Springer Science + Business Media

    Dr Brisa Fernandes

  27. Premenstrual Symptoms Screening Tool--Brazilian Portuguese Version

    Article • January 2016, American Psychological Association (APA)

    Dr Brisa Fernandes

  28. Bias in Peripheral Depression Biomarkers

    Article • Psychotherapy and Psychosomatics, January 2016, Karger Publishers

    Dr Brisa Fernandes

  29. Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis

    Article • Psychoneuroendocrinology, December 2015, Elsevier

    Dr Brisa Fernandes

  30. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies

    Article • BMC Medicine, November 2015, Springer Science + Business Media

    Dr Brisa Fernandes

  31. Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression

    Article • Drugs & Aging, November 2015, Springer Science + Business Media

    Dr Brisa Fernandes

  32. Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder

    Article • Current Neuropharmacology, October 2015, Bentham Science Publishers

    Dr Brisa Fernandes

  33. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

    Article • Molecular Psychiatry, July 2015, Springer Science + Business Media

    Dr Brisa Fernandes

  34. Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders

    Article • Journal of Affective Disorders, February 2015, Elsevier

    Dr Brisa Fernandes

  35. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications

    Article • Molecular Psychiatry, September 2014, Springer Science + Business Media

    Dr Brisa Fernandes

  36. Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis

    Article • Molecular Psychiatry, December 2013, Springer Science + Business Media

    Dr Brisa Fernandes

  37. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies

    Article • Developmental Medicine & Child Neurology, March 2013, Wiley

    Dr Brisa Fernandes

  38. Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force

    Article • Australian & New Zealand Journal of Psychiatry, February 2013, SAGE Publications

    Dr Brisa Fernandes

  39. Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial

    Article • BMC Medicine, August 2012, Springer Science + Business Media

    Dr Brisa Fernandes

  40. Minimum 2-year follow up of sex reassignment surgery in Brazilian male-to-female transsexuals

    Article • Psychiatry and Clinical Neurosciences, May 2012, Wiley

    Dr Brisa Fernandes

  41. Reduced serum non-enzymatic antioxidant defense and increased lipid peroxidation in schizophrenic patients on a hypocaloric diet

    Article • Neuroscience Letters, March 2012, Elsevier

    Dr Brisa Fernandes

  42. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial

    Article • Journal of Affective Disorders, December 2011, Elsevier

    Dr Brisa Fernandes

  43. Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance

    Article • Brazilian Journal of Psychiatry, September 2011, FapUNIFESP (SciELO)

    Dr Brisa Fernandes

  44. Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance

    Article • Brazilian Journal of Psychiatry, September 2011, FapUNIFESP (SciELO)

    Dr Brisa Fernandes

  45. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis

    Article • Journal of Psychiatric Research, August 2011, Elsevier

    Dr Brisa Fernandes

  46. Hypersalivation Associated with Olanzapine and Valproate Combination: A Case Report

    Article • CNS Spectrums, March 2011, Cambridge University Press

    Dr Brisa Fernandes

  47. Improvement of schizophrenia with electroconvulsive therapy and serum brain-derived neurotrophic factor levels: Lack of association in a pilot study

    Article • Psychiatry and Clinical Neurosciences, November 2010, Wiley

    Dr Brisa Fernandes

  48. Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes

    Article • Journal of Psychiatric Research, July 2010, Elsevier

    Dr Brisa Fernandes

  49. Validity of the Portuguese version of the Bipolar Depression Rating Scale

    Article • Acta Neuropsychiatrica, April 2010, Cambridge University Press

    Dr Brisa Fernandes, PEDRO MAGALHAES

  50. Lack of Association Between Serum Brain-Derived Neurotrophic Factor Levels and Improvement of Schizophrenia Symptoms in a Double-Blind, Randomized, Placebo-Controlled Trial of Memantine as Adjunctive Therapy to Clozapine

    Article • The Journal of Clinical Psychiatry, January 2010, Physicians Postgraduate Press, Inc

    Dr Brisa Fernandes

  51. The concept of staging in bipolar disorder: the role of BDNF and TNF-alpha as biomarkers

    Article • Acta Neuropsychiatrica, December 2009, Cambridge University Press

    Dr Brisa Fernandes

  52. Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia

    Article • The Journal of Clinical Psychiatry, October 2009, Physicians Postgraduate Press, Inc

    Dr Brisa Fernandes

  53. Serum brain-derived neurotrophic factor in bipolar and unipolar depression: A potential adjunctive tool for differential diagnosis

    Article • Journal of Psychiatric Research, October 2009, Elsevier

    Dr Brisa Fernandes

  54. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients

    Article • Journal of Psychiatric Research, September 2009, Elsevier

    Dr Brisa Fernandes

  55. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder

    Article • Journal of Affective Disorders, August 2009, Elsevier

    Dr Brisa Fernandes

  56. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patients

    Article • Neuroscience Letters, April 2009, Elsevier

    Dr Brisa Fernandes

  57. Evaluation of the treadmill stress testing for risk stratification after acute myocardial infarction

    Article • Arquivos Brasileiros de Cardiologia, December 1999, FapUNIFESP (SciELO)

    Dr Brisa Fernandes